Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01A
- Chemical subgroupL01AA
- Chemical substanceL01AA06Ifosfamide
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Brazil
Anvisa · 16 registrations
- EvoloxFarmarin Industria e Comercio Ltda
- HoloxaneBaxter Hospitalar Ltda
- IfosfamidaEurofarma Laboratorios S.A.
- LifosBlau Farmacêutica S.A.
Canada
Health Canada · 7 registrations
At a glance
- ATC code
- L01AA06
- Registers
- 9
- Historical lists
- 2
- Registrations
- 43
- With their own page
- 22
- Companies
- 26
All medicines with Ifosfamide
Human medicines from every register that match Ifosfamide by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
45 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Ifosfamide | United States | 1GM/20ML, 1GM/VIAL, 3GM/60ML … | injectable | Marketed | Fresenius Kabi USA |
| Ifosfamide/Mesna KitCombination | United States | 1GM/20ML; 1GM/10ML (50MG/ML, 3GM/60ML; 1GM/10ML (50MG/ML | injectable | Not marketed | Teva Pharms USA |
| Ifex | United States | 1GM/VIAL, 3GM/VIAL | injectable | Marketed | Baxter Hlthcare |
| Ifosfamida | Brazil | Authorised | Eurofarma Laboratorios S.A. | ||
| Ifex/Mesnex KitCombination | United States | 1GM/VIAL; 100MG/ML, 3GM/VIAL; 100MG/ML | injectable | Not marketed | Baxter Hlthcare |
| Ifex | Canada | 1 G / VIAL | Powder For Solution | Marketed | Baxter Corporation |
| Ifex | Canada | 3 G / VIAL | Powder For Solution | Marketed | Baxter Corporation |
| Ifomid-MCombination | New Zealand | Inj 2 g vial with mesna 3 x 100 mg per ml, 4 ml ampoule | Funded | ||
| Ifomid - MCombination | New Zealand | Inj 2 g vial with mesna 3 x 100 mg per ml, 4 ml ampoule | Funded | ||
| Tronoxal 1.000 MG Polvo Para Solución Para Perfusión | Spain | 1 g | polvo para solución para perfusión | Marketed | Baxter S.L. |
| Lifos | Brazil | Authorised | Blau Farmacêutica S.A. | ||
| Holoxan, poeder voor oplossing voor infusie | Netherlands | Poeder voor oplossing voor infusie | Authorised | Baxter B.V. | |
| Holoxan 1000 mg prašak za otopinu za injekciju/infuziju | Croatia | Prašak za otopinu za injekciju / infuziju | Marketed | Baxter d.o.o. | |
| HOLOXAN FOR INJECTION 1 g/25 ml | Singapore | 1 g/25 ml | injection, powder, for solution | Authorised | Baxter Healthcare (Asia) Pte LTD |
| Evolox | Brazil | Authorised | Farmarin Industria e Comercio Ltda | ||
| Holoxan® | Serbia | 1g | prašak za rastvor za injekciju/infuziju | Authorised | Diacell D.O.O. Beograd |
| Holoxane | Brazil | Authorised | Baxter Hospitalar Ltda | ||
| Holoxan 500 mg prašak za otopinu za injekciju/infuziju | Croatia | Prašak za otopinu za injekciju / infuziju | Not marketed | Baxter d.o.o. | |
| Holoxan | New Zealand | Inj 1 g | Funded | ||
| Holoxan | New Zealand | Inj 2 g | Funded | ||
| Holoxan | New Zealand | Inj 1 g vial | Funded | ||
| Holoxan | New Zealand | Inj 2 g vial | Funded | ||
| Holoxan 1GM I.V. Vial | Saudi Arabia | Authorised | Baxter Oncology | ||
| Holoxan 2GM IV. Vial | Saudi Arabia | Authorised | Baxter Oncology | ||
| Holoxan 500MG Vial IV | Saudi Arabia | Authorised | Baxter Oncology |